InstalabCardiolipin Antibodies
Should you take a Cardiolipin Antibodies test?
This test is most useful if any of these apply to you.
3 Biomarkers Included
- Cardiolipin Antibody IgGThe most informative marker in the panel. This long-term antibody carries the strongest link to abnormal clotting in both veins and arteries.A persistent, medium-to-high IgG result is the clearest sign that these antibodies may be raising your clotting risk.
- Cardiolipin Antibody IgMAn early-response antibody that adds the most in pregnancy-related cases. On its own it has a weaker connection to clotting than IgG.Isolated IgM matters more for recurrent pregnancy loss than for unexplained blood clots.
- Cardiolipin Antibody IgAA supporting marker that occasionally flags added risk but is not part of formal diagnostic criteria and rarely appears by itself.IgA positivity alone is uncommon and usually adds little unless IgG or IgM is also positive.
About Cardiolipin Antibodies
A blood clot in a young, otherwise healthy person, or a run of miscarriages with no clear explanation, can leave you searching for a cause. One possibility sits in your immune system: antibodies that mistakenly target cardiolipin, a fatty building block of your cells. When these antibodies stick around, they can push your blood toward clotting.
This panel measures those antibodies in their three immune-protein classes at once. The value is in the pattern, because which classes show up, and how strongly, says more about your risk than a single positive result on its own.
What This Panel Reveals
Cardiolipin antibodies are one of the main signals clinicians look for when investigating antiphospholipid syndrome (an autoimmune condition that makes blood clot too easily). It shows up as clots in veins or arteries, or as pregnancy complications. This panel captures the antibody side of that picture.
Your immune system makes antibodies in different classes, and here three are measured. The IgG class (a long-term antibody) carries the strongest link to clotting. The IgM class (an early-response antibody) matters more in pregnancy-related cases. The IgA class is a supporting marker that occasionally adds information but rarely stands on its own.
Testing all three together shows whether your antibody response is narrow or broad. A response spread across classes, especially when it includes IgG, tends to mark higher risk than a single isolated class.
How to Read Your Results Together
No single number tells the whole story. What matters is which class is positive, how high the level is, and whether the result holds up on a repeat test.
| Pattern | What It Suggests |
|---|---|
| IgG positive at medium or high level | The strongest clotting-related signal in this panel, especially alongside other antiphospholipid markers. |
| IgM positive, IgG negative | Weaker link to clots. More relevant when the concern is recurrent pregnancy loss. |
| IgA positive alone | Uncommon and hard to interpret. Rarely meaningful without IgG or IgM also positive. |
| Any positive on a first test | Not enough on its own. Needs confirmation on a second test at least 12 weeks later. |
In adults without lupus, testing positive for cardiolipin antibodies has been linked to more clots: roughly one and a half times the odds of a vein clot (odds ratio 1.46, 95% confidence interval 1.06 to 2.03) and about two and a half times the odds of an artery clot (odds ratio 2.65, 95% confidence interval 1.75 to 4.00). A related clotting antibody test, lupus anticoagulant, carries an even stronger signal, which is why this panel is read as part of a group rather than in isolation.
What to Do with Your Results
A positive result is a starting point, not a diagnosis. Confirm it with a repeat test at least 12 weeks later, because infections, medications, and even pregnancy can produce antibodies that fade on their own. Formal classification of antiphospholipid syndrome requires two positive results this far apart.
Pair this panel with the other two antiphospholipid tests, lupus anticoagulant and anti-beta-2-glycoprotein I antibodies, since the three read best together. When all three are positive, a pattern called triple positivity, the clotting risk is highest. Under the 2023 classification criteria, cardiolipin antibody levels are graded as moderate at 40 to 79 units and high at 80 units or more, with higher levels weighted more heavily. A hematologist or rheumatologist can weigh your antibody pattern against your personal and family history and decide whether treatment or monitoring makes sense.
When Results Can Be Misleading
These antibodies can appear briefly after an infection or illness and then disappear, which is why a single result means little. Testing done right around a clotting event can also mislead, so timing matters.
The laboratory method matters too. Cardiolipin antibody results vary considerably between labs and testing platforms, particularly for the IgM class and for low-positive results. For any repeat test, use the same laboratory when you can, and treat borderline results with caution.